Essential phospholipids impact cytokine secretion and alter lipid-metabolizing enzymes in human hepatocyte cell lines
Pharmacological Reports · 2024
DOI: 10.1007/s43440-024-00595-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacological Reports, 2024. Verfasst von Dominik Wupperfeld und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Technology and Biopharmacy, Institute of Pharmacy and Molecular Biotechnology, Ruprecht-Karls University of Heidelberg, …. Hauptthemen laut MEDLINE: Hepatocytes, Phospholipids, Lipid Metabolism. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sanofi.
Abstract (Originalsprache)
Background
Essential phospholipids (EPL) are hepatoprotective.
Methods
The effects on interleukin (IL)-6 and -8 secretion and on certain lipid-metabolizing enzymes of non-cytotoxic concentrations of EPL (0.1 and 0.25 mg/ml), polyenylphosphatidylcholine (PPC), and phosphatidylinositol (PtdIns) (both at 0.1 and 1 mg/ml), compared with untreated controls, were assessed in human hepatocyte cell lines (HepG2, HepaRG, and steatotic HepaRG).
Results
Lipopolysaccharide (LPS)-induced IL-6 secretion was significantly decreased in HepaRG cells by most phospholipids, and significantly increased in steatotic HepaRG cells with at least one concentration of EPL and PtdIns. LPS-induced IL-8 secretion was significantly increased in HepaRG and steatotic HepaRG cells with all phospholipids. All phospholipids significantly decreased amounts of fatty acid synthase in steatotic HepaRG cells and the amounts of acyl-CoA oxidase in HepaRG cells. Amounts of lecithin cholesterol acyltransferase were significantly decreased in HepG2 and HepaRG cells by most phospholipids, and significantly increased with 0.1 mg/ml PPC (HepaRG cells) and 1 mg/ml PtdIns (steatotic HepaRG cells). Glucose-6-phosphate dehydrogenase activity was unaffected by any phospholipid in any cell line.
Conclusions
EPL, PPC, and PtdIns impacted the secretion of pro-inflammatory cytokines and affected amounts of several key lipid-metabolizing enzymes in human hepatocyte cell lines. Such changes may help liver function improvement, and provide further insights into the EPL’s mechanism of action.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Technology and Biopharmacy, Institute of Pharmacy and Molecular Biotechnology, Ruprecht-Karls University of Heidelberg, Heidelberg, Germany.
- Sanofi, Neuilly-Sur-Seine, France.
- Sanofi, Frankfurt am Main, K607, 65929, Industriepark Hoechst, Germany. Branko.Popovic@sanofi.com.
Förderung
- Sanofi
Zitieren
APA
Wupperfeld, D., Fricker, G., Bois De Fer, B., & Popovic, B. (2024). Essential phospholipids impact cytokine secretion and alter lipid-metabolizing enzymes in human hepatocyte cell lines. Pharmacological Reports. https://doi.org/10.1007/s43440-024-00595-4
Vancouver
Wupperfeld D, Fricker G, Bois De Fer B, Popovic B. Essential phospholipids impact cytokine secretion and alter lipid-metabolizing enzymes in human hepatocyte cell lines. Pharmacological Reports. 2024. doi:10.1007/s43440-024-00595-4
BibTeX
@article{Wupperfeld2024,
author = {Wupperfeld, Dominik and Fricker, Gert and Bois De Fer, Béatrice and Popovic, Branko},
title = {Essential phospholipids impact cytokine secretion and alter lipid-metabolizing enzymes in human hepatocyte cell lines},
journal = {Pharmacological Reports},
year = {2024},
doi = {10.1007/s43440-024-00595-4}
}
EUVIMED